Dr. Ming Zhou, MD

Dr. Zhou practices at Central Valley Specialty Hospital in Modesto, California, part of Central Valley Specialty Hospital.

Dr. Zhou's NPI, 1619933850, was assigned on April 25, 2006. Dr. Zhou graduated from Xuzhou Medical College in 1984. Dr. Zhou holds California license A82941.

Dr. Zhou's primary practice is Central Valley Specialty Hospital, at 730 17th Street, Modesto, CA 95354 in Stanislaus County. The practice phone is (209) 248-7700.

Dr. Zhou's primary practice is Central Valley Specialty Hospital in Modesto, California, part of Central Valley Specialty Hospital. Dr. Zhou is also affiliated with Memorial Medical Center. The medical group on file is SGMF Radiology. Dmand AI also links Dr. Zhou to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zhou practices, 5 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Zhou's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Zhou is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Zhou's licenses on file in 2 states: California and Connecticut.

Dmand AI lists arterial blot clot /embolism, chronic anemia, chronic leukemia, deep vein thrombosis (DVT), lung cancer, lymphoma, multiple myeloma and neutropenia among the conditions Dr. Zhou treats.

CMS data shows 2,153 Medicare services from Dr. Zhou across 9 procedure codes in 2024, for 753 Medicare patients. Medicare paid $202,152 for them.

CMS counts 753 Medicare patients who saw Dr. Zhou in 2024. The largest group is 65 to 74, with 319 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 1.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zhou's median patient age at 71, with 60% women.

In 2024, Dr. Zhou wrote 2,010 Medicare Part D claims for 343 patients. 88% of them were for generic drugs. CMS names the drug for 1,762 of them, across 30 drugs with 11 or more claims each, at $2,986,606 in total drug cost. In 2023, CMS named 1,554 claims across 28 drugs.

Dr. Zhou accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Zhou as offering telehealth.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 36 papers to Dr. Zhou, published from 2005 to 2023. 2012 was the busiest year, with 3. The most frequent topics are Immunohistochemistry, Biomarkers, Tumor and Kidney Neoplasms. Dr. Zhou has published most often in Am J Surg Pathol. Dr. Zhou's most frequent co-authors are Guiyuan Li, MD, PhD, Sara Moscovita Falzarano, MD and Jonathan Ira Epstein, MD.

CMS Open Payments shows 212 general payments to Dr. Zhou from 37 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 65% of the total. AstraZeneca Pharmaceuticals LP paid the most, $4,766.

Dmand AI lists 1 award for Dr. Zhou, most recently CMS Stage 1 EHR in 2013.

Dr. Zhou graduated from Xuzhou Medical College in 1984.

Dr. Zhou is in network with 13 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.